CrushSCI.com
155.7平均天数
155中位天数
52最短天数
267最长天数
5812025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

118 天

Adaptor AP4M1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis through USP15-mediated deubiquitination and MINK1-dependent phosphorylation

作者
Yuanhao Peng; Kuo Kang; Xuanxuan Li; Minmin Xiang; Yanling Zhou; Shuang Liu; Desheng Xiao; Hong Zhu; Yongguang Tao; Yangying Zhou展开收起
作者单位
Department of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, China展开收起
PDF源文件 DOI 网页
119 天

Regulation of ubiquitination and degradation of the gap junction channel protein Connexin43 involves the concerted action of multiple members of the NEDD4 family of E3 ubiquitin ligases

作者
Max Zachrisson Totland; Nikoline Lander Rasmussen; Vilde Cecilie Wivestad Elster; Karen Irene Arnesen; Dina Glømmi Bergmann; Ida Bergill; Jakob Mørkved Stenersen; Mathias Larsen; Joachim Jordal Moe; Sebastian Basing; Vigdis Sørensen; Trond Aasen; Edward Leithe展开收起
作者单位
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, 0379, Norway; Translational Molecular Pathology, Vall d’Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d’Hebron (IIS IR-HUVH), CIBERONC, Instituto de Salud Carlos III, Barcelona, Spain展开收起
PDF源文件 DOI 网页
130 天

Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses

作者
Hatice Satilmis; Emma Verheye; Sylvia Faict; Robbe Heestermans; Ann De Becker; Karin Vanderkerken; Elke De Bruyne; Eline Menu; Erica K. Sloan; Kim De Veirman展开收起
作者单位
Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Hematology Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels, 1090, Belgium; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia展开收起
PDF源文件 DOI 网页
160 天

Arginine methyltransferase PRMT3 suppresses tumor-intrinsic immunity via promoting cGAS methylation

作者
Yu Chen; Yang Liu; Jianfeng Peng; Xiaolong Wang; Zhonghui Wei; Xiaoyan Yin; Xueying Zhai; Yankang Li; Jinming Yu; Xiangjiao Meng展开收起
作者单位
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Cheeloo College of Medicine, Shandong University Cancer Center, Jinan, Shandong, China; Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Beijing, China展开收起
PDF源文件 DOI 网页
155 天

Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model

作者
Dinesh Kumar; Vanesa Silvestri; Elijah F. Edmondson; Imran Khan; Wei Zhang; Debbie Wei; Christina Robinson; Alexandra S. Zimmer; Stanley Lipkowitz; Simone Difilippantonio; Patricia S. Steeg展开收起
作者单位
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA; Animal Research Technical Support, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; Molecular Histopathology Lab, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA展开收起
PDF源文件 DOI 网页
176 天

USP22 enhances mitochondrial biogenesis via stabilizing MYBBP1A in non-small cell lung cancer

作者
Yue Sun; Fang Zhen; Hongyi Wang; Huiyuan Tian; Le Wang; Zhanpeng Liu; Jing Hu展开收起
作者单位
Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, No. 150 Haping Road, Harbin, Heilongjiang Province, 150040, China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。